138 related articles for article (PubMed ID: 2512219)
1. [Prognostic factors in multiple myeloma].
Boccadoro M; Bianchi A; Dianzani U; Frieri R; Gallone G; Massaia M; Omede P; Palumbo A; Pileri A
Haematologica; 1989 Oct; 74(5 Suppl):347-57. PubMed ID: 2512219
[No Abstract] [Full Text] [Related]
2. Multiple complications in multiple myeloma.
Basi S; Schulman G; Fogo AB
Am J Kidney Dis; 2005 Mar; 45(3):619-23. PubMed ID: 15754288
[No Abstract] [Full Text] [Related]
3. [Multiple myeloma. Mechanisms of proliferation and neoplastic progression and their clinical implications].
Boccadoro M; Battaglio S; Dianzani U; Frieri R; Gallone G; Massaia M; Omedè P; Palumbo A; Pileri A
Haematologica; 1991 Jun; 76 Suppl 3():100-6. PubMed ID: 1752506
[No Abstract] [Full Text] [Related]
4. Beta-2-microglobulin in multiple myeloma.
Musarurwa C; Matarira HT
Cent Afr J Med; 2004; 50(1-2):19-20. PubMed ID: 15490720
[No Abstract] [Full Text] [Related]
5. Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma.
Gertz MA; Lacy MQ; Inwards DJ; Chen MG; Pineda AA; Gastineau DA; Greipp PR; Lust JA; Tefferi A; Witzig TE; Kyle RA; Litzow MR
Bone Marrow Transplant; 1999 Feb; 23(3):221-6. PubMed ID: 10084252
[TBL] [Abstract][Full Text] [Related]
6. [Multiple myeloma. Clinical review of 56 cases].
López Alvarez J; Sanz Marca A; Aboin Massieu FJ
Rev Clin Esp; 1983 Nov; 171(3):175-8. PubMed ID: 6669751
[No Abstract] [Full Text] [Related]
7. [Renal insufficiency and myeloma: therapeutic success in relation to reduction of tumor mass].
Bondía Román A; San Miguel J; Guervos CS; Batlle F; Tabernero Romo JM; López-Borrasca A
Rev Clin Esp; 1982 Feb; 164(3):191-2. PubMed ID: 7089337
[No Abstract] [Full Text] [Related]
8. Reply. Kastritis E. et al. Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone containing regimes and the impact of novel agents. Haematologica 2007; 92:546-9.
Bergner R; Hoffmann M; Uppenkamp M
Haematologica; 2008 Jan; 93(1):e18-9. PubMed ID: 18166771
[No Abstract] [Full Text] [Related]
9. Multiple myeloma: prognostic factors and treatment modalities.
Michiels JJ
Neth J Med; 1992 Jun; 40(5-6):254-70. PubMed ID: 1436263
[No Abstract] [Full Text] [Related]
10. Prognostic factors in multiple myeloma.
Kyle RA
Stem Cells; 1995 Aug; 13 Suppl 2():56-63. PubMed ID: 8520513
[TBL] [Abstract][Full Text] [Related]
11. Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.
Rajkumar S; Fonseca R; Lacy M; Witzig T; Lust J; Greipp P; Therneau T; Kyle R; Litzow M; Gertz M
Bone Marrow Transplant; 1999 Sep; 24(5):497-503. PubMed ID: 10482933
[TBL] [Abstract][Full Text] [Related]
12. [Multiple myeloma: description of a series of 170 cases].
Bladé J; Rozman C; Montserrat E; Grañena A; Brugués R; Cervantes F; Feliu E; Marín P; Nomdedeu B; Vives-Corrons JL
Med Clin (Barc); 1984 Feb; 82(7):287-94. PubMed ID: 6717133
[No Abstract] [Full Text] [Related]
13. [The prognostic significance of the beta 2-microglobulin level of the blood serum in multiple myeloma patients].
Lubo-Lesnichenko IF; Bessmel'tsev SS; Abdulkadyrov KM; Blinov MN; Stel'mashenko LV
Ter Arkh; 1996; 68(10):28-31. PubMed ID: 9026938
[TBL] [Abstract][Full Text] [Related]
14. [Clinical aspects of multiple myeloma].
López Alvarez J; Sanz Marca A; Aboin Massieu FJ
Rev Clin Esp; 1983 Nov; 171(3):165-74. PubMed ID: 6366936
[No Abstract] [Full Text] [Related]
15. Multiple myeloma with Auer-rod-like inclusions.
Castoldi G; Piva N; Tomasi P
Haematologica; 1999 Sep; 84(9):859-60. PubMed ID: 10477463
[No Abstract] [Full Text] [Related]
16. [Light chain myeloma: clinical study and prognostic factors ].
Redón J; Caballero M; Herranz C
Med Clin (Barc); 1982 Jun 16-30; 79(2):54-8. PubMed ID: 6811809
[No Abstract] [Full Text] [Related]
17. [Multidrug resistance in hematological malignancies: prognostic significance and the effect of resistance-modulating drugs].
Sonneveld P; te Boekhorst PA
Ned Tijdschr Geneeskd; 1994 Mar; 138(10):508-12. PubMed ID: 7908127
[No Abstract] [Full Text] [Related]
18. New prognostic factors in multiple myeloma.
Bettini R; Rapazzini P; Marrapodi E
Haematologica; 1987; 72(1):102-3. PubMed ID: 3108088
[No Abstract] [Full Text] [Related]
19. Alpha(v)beta(3) integrin engagement enhances cell invasiveness in human multiple myeloma.
Ria R; Vacca A; Ribatti D; Di Raimondo F; Merchionne F; Dammacco F
Haematologica; 2002 Aug; 87(8):836-45. PubMed ID: 12161360
[TBL] [Abstract][Full Text] [Related]
20. The use of biological variables to predict outcome in multiple myeloma.
Davies FE; Jack AS; Morgan GJ
Br J Haematol; 1997 Dec; 99(4):719-25. PubMed ID: 9432013
[No Abstract] [Full Text] [Related]
[Next] [New Search]
